Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Image with the COVID germ graphic and the words "LONG COVID" in big white letters
    9 April 2024

    COVID-19 BioResource participants in new study identifying key trigger of long COVID

    Volunteer data from our COVID-19 BioResource has been used in a new study, published by Nature Immunology, which discovered that problems with iron levels in the blood and the body’s ability to regulate this important nutrient as a result of SARS-CoV-2 infection could be a key trigger f...

    GLAD logo showing 8 silhouettes, 4 yellow, 4 blue with the words "Now Recruiting Control Participants"
    4 April 2024

    GLAD Study opens recruitment for participants without history of mental health condition

    The Genetic Links to Anxiety and Depression (GLAD) Study, part of our Mental Health BioResource, is thrilled to announce the launch of a recruitment drive for individuals without a history of anxiety and depression. In a world where millions are affected by mental health struggles like ...

    Photo of patient's arm providing a blood sample, with nurse's hand carrying out the procedure
    26 March 2024

    Get to know the Specialised Laboratory teams at the NIHR BioResource

    A look at the role of the Specialised Laboratory teams at the NIHR BioResource: who they are, what a regular day looks like, key projects they are working on, how they interact with other teams and processes at the BioResource and challenges they face. ...

    Innovia-Technology-Innovation-Consultancy-Interns-2024-Breakthrough-Holistic-Innovators-Complex-Problem-Solvers
    1 August 2024

    Innovia Technology: through the eyes of our interns

    What makes for a good internship?

    SpyLock technology for the rapid generation of bispecific antibodies
    31 July 2024

    Bio-Rad's study demonstrating utility of its SpyLock technology for fast generation and screening of bispecific antibodies

    Study Describes Method to Successfully Modify the Functional Activity of SpyCatcher Protein for the Rapid Generation and High-Throughput Screening of Bispecific Antibodies ...

    The end of high drug prices? Exploring the potential and limits of PDABs
    31 July 2024

    The end of high drug prices? Exploring the potential and limits of PDABs

    Certain states in the US have enacted or are actively considering legislation to create PDABs, Prescription Drug Affordability Boards. PDABs are independent state bodies comprised of experts in healthcare and economics, empowered to analyze drug costs and suggest ways to lower stat...

    Ethics of artificial intelligence in the life sciences industry
    9 July 2024

    Ethics of artificial intelligence in the life sciences industry

    This podcast is part of the Life Sciences 2030 initiative that explores ethics of artificial intelligence (AI) in the life sciences industry. Moderated by Kristen Backor with panelists Michelle Guo, Travis Ruch, and Artes Haderi, the discussion highlights AI’s potential to revolutionize...

    Asimov CHO Edge System
    30 July 2024

    Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee

    Enables unique vector and process optimizations for different molecules to increase the likelihood of high titer clonal cell lines. Asimov now guarantees titers of 5 g/L for IgG monoclonal antibodies, as part of its Cell Line Development (CLD) Service Boston, Massachusetts, 30 Jul...

    Andrew Wyatt, Chief Growth Officer, Sapio Sciences
    30 July 2024

    Sapio Sciences and Zifo announce strategic partnership

    Industry leaders to provide world-class lab informatics platform, services and support to life science customers Baltimore, MD, 30 July 2024 – Sapio Sciences, the science-aware™ lab informatics platform, and Zifo, the leading scientific informatics services company, announces a stra...

    Springboard's Human Factors observation room
    30 July 2024

    Introducing our state-of-the-art human factors study facility

    Springboard Pro Ltd writes: we are pleased to announce an enhancement to our human factors capabilities with the introduction of our new dedicated human factors facility. With only a few available in the area, this gives our clients easier and faster access to custom-built facilities. ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 125
    • Page 126
    • Current page 127
    • Page 128
    • Page 129
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS